Garland Capital Management Inc has filed its 13F form on April 30, 2024 for Q1 2024 where it was disclosed a total value porftolio of $151 Million distributed in 33 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Jpmorgan Chase & CO with a value of $9.11M, Merck & Co., Inc. with a value of $8.25M, Abb Vie Inc. with a value of $8.13M, Travelers Companies, Inc. with a value of $7.01M, and Procter & Gamble CO with a value of $6.83M.
Examining the 13F form we can see an increase of $8.55M in the current position value, from $142M to 151M.
Below you can find more details about Garland Capital Management Inc portfolio as well as his latest detailed transactions.